BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37201322)

  • 1. Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells.
    Stojković P; Kostić A; Lupšić E; Jovanović NT; Novaković M; Nedialkov P; Trendafilova A; Pešić M; Opsenica IM
    Bioorg Chem; 2023 Sep; 138():106605. PubMed ID: 37201322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma.
    Stepanović A; Terzić Jovanović N; Korać A; Zlatović M; Nikolić I; Opsenica I; Pešić M
    Biomed Pharmacother; 2024 May; 174():116496. PubMed ID: 38537581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
    Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
    Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.
    Podolski-Renić A; Bősze S; Dinić J; Kocsis L; Hudecz F; Csámpai A; Pešić M
    Metallomics; 2017 Aug; 9(8):1132-1141. PubMed ID: 28737782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.
    Dačević M; Isaković A; Podolski-Renić A; Isaković AM; Stanković T; Milošević Z; Rakić L; Ruždijić S; Pešić M
    PLoS One; 2013; 8(1):e54044. PubMed ID: 23326571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
    Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel spiro-quinazolinone derivatives as chitin synthase inhibitors and antifungal agents.
    Du C; Yang X; Long Y; Lang X; Liu L; Xu Y; Wu H; Chu Y; Hu X; Deng J; Ji Q
    Eur J Med Chem; 2023 Jul; 255():115388. PubMed ID: 37141707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.
    Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
    Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
    Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
    Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
    Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
    Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
    Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor.
    Riganti C; Giampietro R; Kopecka J; Costamagna C; Abatematteo FS; Contino M; Abate C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of η
    Pazinato J; Cruz OM; Naidek KP; Pires ARA; Westphal E; Gallardo H; Baubichon-Cortay H; Rocha MEM; Martinez GR; Winnischofer SMB; Di Pietro A; Winnischofer H
    Eur J Med Chem; 2018 Mar; 148():165-177. PubMed ID: 29459276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.
    Bakadlag R; Limniatis G; Georges G; Georges E
    BMC Cancer; 2023 Jan; 23(1):24. PubMed ID: 36609245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.
    Lin AJ; Russell CC; Baker JR; Frailey SL; Sakoff JA; McCluskey A
    Org Biomol Chem; 2016 Sep; 14(37):8732-8742. PubMed ID: 27714138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations.
    Xiao Z; Zhou Z; Chu C; Zhang Q; Zhou L; Yang Z; Li X; Yu L; Zheng P; Xu S; Zhu W
    Eur J Med Chem; 2020 Oct; 203():112511. PubMed ID: 32679450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.